345 related articles for article (PubMed ID: 28730283)
1. Blockade of alcohol escalation and "relapse" drinking by pharmacological FAAH inhibition in male and female C57BL/6J mice.
Zhou Y; Schwartz BI; Giza J; Gross SS; Lee FS; Kreek MJ
Psychopharmacology (Berl); 2017 Oct; 234(19):2955-2970. PubMed ID: 28730283
[TBL] [Abstract][Full Text] [Related]
2. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
Cippitelli A; Cannella N; Braconi S; Duranti A; Tontini A; Bilbao A; Defonseca FR; Piomelli D; Ciccocioppo R
Psychopharmacology (Berl); 2008 Jul; 198(4):449-60. PubMed ID: 18446329
[TBL] [Abstract][Full Text] [Related]
3. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
Danandeh A; Vozella V; Lim J; Oveisi F; Ramirez GL; Mears D; Wynn G; Piomelli D
Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159
[TBL] [Abstract][Full Text] [Related]
4. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
Slivicki RA; Xu Z; Mali SS; Hohmann AG
Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
[TBL] [Abstract][Full Text] [Related]
5. Manipulation of fatty acid amide hydrolase functional activity alters sensitivity and dependence to ethanol.
Vinod KY; Sanguino E; Yalamanchili R; Manzanares J; Hungund BL
J Neurochem; 2008 Jan; 104(1):233-43. PubMed ID: 17944864
[TBL] [Abstract][Full Text] [Related]
6. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
Russo R; Loverme J; La Rana G; Compton TR; Parrott J; Duranti A; Tontini A; Mor M; Tarzia G; Calignano A; Piomelli D
J Pharmacol Exp Ther; 2007 Jul; 322(1):236-42. PubMed ID: 17412883
[TBL] [Abstract][Full Text] [Related]
7. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
Bosier B; Muccioli GG; Lambert DM
Br J Pharmacol; 2013 Jun; 169(4):794-807. PubMed ID: 22970888
[TBL] [Abstract][Full Text] [Related]
8. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
Moreira FA; Kaiser N; Monory K; Lutz B
Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Endocannabinoids in Alcohol "Binge" Drinking: Studies of Mice with Human Fatty Acid Amide Hydrolase Genetic Variation and After CB1 Receptor Antagonists.
Zhou Y; Huang T; Lee F; Kreek MJ
Alcohol Clin Exp Res; 2016 Mar; 40(3):467-73. PubMed ID: 26857901
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B
Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
Fidelman S; Mizrachi Zer-Aviv T; Lange R; Hillard CJ; Akirav I
Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
[TBL] [Abstract][Full Text] [Related]
12. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system.
Okine BN; Norris LM; Woodhams S; Burston J; Patel A; Alexander SP; Barrett DA; Kendall DA; Bennett AJ; Chapman V
Br J Pharmacol; 2012 Oct; 167(3):627-40. PubMed ID: 22595021
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
Nozaki C; Markert A; Zimmer A
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1388-96. PubMed ID: 25910421
[TBL] [Abstract][Full Text] [Related]
14. Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in Mice.
Owens RA; Ignatowska-Jankowska B; Mustafa M; Beardsley PM; Wiley JL; Jali A; Selley DE; Niphakis MJ; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2016 Aug; 358(2):306-14. PubMed ID: 27307500
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.
Li H; Wood JT; Whitten KM; Vadivel SK; Seng S; Makriyannis A; Avraham HK
Br J Pharmacol; 2013 Oct; 170(3):489-505. PubMed ID: 23347118
[TBL] [Abstract][Full Text] [Related]
16. Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints.
Krustev E; Reid A; McDougall JJ
Arthritis Res Ther; 2014 Sep; 16(5):437. PubMed ID: 25260980
[TBL] [Abstract][Full Text] [Related]
17. Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.
Slivicki RA; Saberi SA; Iyer V; Vemuri VK; Makriyannis A; Hohmann AG
J Pharmacol Exp Ther; 2018 Dec; 367(3):551-563. PubMed ID: 30275151
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats.
Biernacki M; Łuczaj W; Gęgotek A; Toczek M; Bielawska K; Skrzydlewska E
Toxicol Appl Pharmacol; 2016 Jun; 301():31-41. PubMed ID: 27086176
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposure.
Rivera P; Fernández-Arjona MDM; Silva-Peña D; Blanco E; Vargas A; López-Ávalos MD; Grondona JM; Serrano A; Pavón FJ; Rodríguez de Fonseca F; Suárez J
Biochem Pharmacol; 2018 Nov; 157():244-257. PubMed ID: 30098312
[TBL] [Abstract][Full Text] [Related]
20. Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPARα and CB1 receptor mechanism, respectively: a double dissociation.
Rock EM; Limebeer CL; Ward JM; Cohen A; Grove K; Niphakis MJ; Cravatt BF; Parker LA
Psychopharmacology (Berl); 2015 Oct; 232(20):3841-8. PubMed ID: 26297326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
